These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 9200344

  • 21. [Efficacy of a very low molecular weight heparin fragment (CY 222) compared to standard heparin in patients with deep venous thrombosis. A randomized study].
    Faivre R, Neuhart E, Kieffer Y, Bassand JP, Maurat JP.
    J Mal Vasc; 1987; 12 Suppl B():145-6. PubMed ID: 2834488
    [Abstract] [Full Text] [Related]

  • 22. Management of venous thromboembolic disease. The impact of low-molecular-weight heparin.
    Tapson VF, Hull RD.
    Clin Chest Med; 1995 Jun; 16(2):281-94. PubMed ID: 7656540
    [Abstract] [Full Text] [Related]

  • 23. Low molecular weight heparins--state-of-the-art and unsolved issues.
    Breddin HK.
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S17-9. PubMed ID: 8180324
    [Abstract] [Full Text] [Related]

  • 24. Long-term clinical follow-up in 265 patients with deep venous thrombosis initially treated with either unfractionated heparin or dalteparin: a retrospective analysis.
    Holmström M, Aberg W, Lockner D, Paul C.
    Thromb Haemost; 1999 Oct; 82(4):1222-6. PubMed ID: 10544902
    [Abstract] [Full Text] [Related]

  • 25. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG.
    Eur J Med Res; 2004 Apr 30; 9(4):225-39. PubMed ID: 15210403
    [Abstract] [Full Text] [Related]

  • 26. [Meta-analysis on randomized trials comparing the results of low-molecular weight heparins to those of fractioned heparins in the prevention of deep venous thrombosis].
    Daures JP, Schved JF, Momas I, Gril JC, Azoulay P, Gremy F.
    Rev Epidemiol Sante Publique; 1989 Apr 30; 37(4):363-9. PubMed ID: 2558404
    [Abstract] [Full Text] [Related]

  • 27. Spontaneous lysis of deep venous thrombi: rate and outcome.
    Killewich LA, Bedford GR, Beach KW, Strandness DE.
    J Vasc Surg; 1989 Jan 30; 9(1):89-97. PubMed ID: 2911146
    [Abstract] [Full Text] [Related]

  • 28. The potential role of thrombolytic therapy in venous thrombosis.
    Markel A, Manzo RA, Strandness DE.
    Arch Intern Med; 1992 Jun 30; 152(6):1265-7. PubMed ID: 1599356
    [Abstract] [Full Text] [Related]

  • 29. Prospective 12-year follow-up study of clinical and hemodynamic sequelae after deep vein thrombosis in low-risk patients (Zürich study).
    Franzeck UK, Schalch I, Jäger KA, Schneider E, Grimm J, Bollinger A.
    Circulation; 1996 Jan 01; 93(1):74-9. PubMed ID: 8616945
    [Abstract] [Full Text] [Related]

  • 30. Treatment of deep vein thrombosis: is thrombosis regression a desirable endpoint?
    Breddin HK.
    Semin Thromb Hemost; 1997 Jan 01; 23(2):179-83. PubMed ID: 9200344
    [Abstract] [Full Text] [Related]

  • 31. [The treatment of deep venous thrombosis. Thrombolysis vs heparin].
    Schmutzler R.
    Phlebologie; 1990 Jan 01; 43(4):656-65; discussion 666. PubMed ID: 2093922
    [Abstract] [Full Text] [Related]

  • 32. Prophylaxis and treatment of deep vein thrombosis in general surgery.
    Gutt CN, Oniu T, Wolkener F, Mehrabi A, Mistry S, Büchler MW.
    Am J Surg; 2005 Jan 01; 189(1):14-22. PubMed ID: 15701484
    [Abstract] [Full Text] [Related]

  • 33. [Deep venous thromboses--established treatment procedures and new trends].
    Seifried E.
    Z Kardiol; 1993 Jan 01; 82 Suppl 2():49-59. PubMed ID: 8328209
    [Abstract] [Full Text] [Related]

  • 34. Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.
    Harenberg J, Stehle G, Blauth M, Huck K, Mall K, Heene DL.
    Semin Thromb Hemost; 1997 Jan 01; 23(1):83-90. PubMed ID: 9156415
    [Abstract] [Full Text] [Related]

  • 35. Treatment of deep vein thrombosis: is thrombosis regression a desirable endpoint?
    Breddin HK.
    Semin Thromb Hemost; 1997 Jan 01; 23(2):179-83. PubMed ID: 9200344
    [Abstract] [Full Text] [Related]

  • 36. [The treatment of deep venous thrombosis. Thrombolysis vs heparin].
    Schmutzler R.
    Phlebologie; 1990 Jan 01; 43(4):656-65; discussion 666. PubMed ID: 2093922
    [Abstract] [Full Text] [Related]

  • 37. Prophylaxis and treatment of deep vein thrombosis in general surgery.
    Gutt CN, Oniu T, Wolkener F, Mehrabi A, Mistry S, Büchler MW.
    Am J Surg; 2005 Jan 01; 189(1):14-22. PubMed ID: 15701484
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.
    Harenberg J, Stehle G, Blauth M, Huck K, Mall K, Heene DL.
    Semin Thromb Hemost; 1997 Jan 01; 23(1):83-90. PubMed ID: 9156415
    [Abstract] [Full Text] [Related]

  • 40. Treatment of deep vein thrombosis: is thrombosis regression a desirable endpoint?
    Breddin HK.
    Semin Thromb Hemost; 1997 Jan 01; 23(2):179-83. PubMed ID: 9200344
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.